Elis annonce l'acquisition de RS10 en Espagne
HealthcareAdd-on
Elis→RS10 Servicios Tratamientos y mantenimientos de Tejidos
Jun 9, 2026
Vega Therapeutics Acquired by Incyte | Healthcare M&A Deal
Announced
HealthcareRhode IslandPlatform
Deal Overview
Incyte has acquired Vega Therapeutics, a healthcare services other business in Rhode Island, for $2 billion. Incyte acquisitions focus on expanding healthcare M&A capabilities through Vega Therapeutics’ pipeline and development programs. Vega Therapeutics supports drug discovery and clinical development activities that align with Incyte’s strategic acquisition goals in RI acquisitions. The platform acquisition is classified as a strategic acquisition and is part of broader healthcare deals RI, with deal size over $100M and an announced status.
Key Details
- Transaction
- Incyte acquires Vega Therapeutics
- Deal Size
- Over $100M
- Reported Value
- $2 billion
Filed under
Powered by Tentt
Source healthcare deals in Rhode Island for your firm
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Johnson & Johnson to Acquire Firefly Bio, Inc. to Expand Oncology Pipeline with Novel Degrader Antibody Conjugate Platform - BioSpace
HealthcareOther
Johnson & Johnson→Firefly Bio
Jun 9, 2026
Galmed to acquire Colospan for USD 4.5M - Medical Buyer
HealthcareOther
Galmed→Colospan
Jun 9, 2026
Standard BioTools Inc. (LAB) Discusses Merger and Strategic Rationale Prepared Remarks Transcript
HealthcareMerger
Standard BioTools
Jun 9, 2026
Incyte’s $1.25B Buyout Brings What Could Become the Next Big Bleeding Disorder Drug
HealthcareAcquisition
Incyte→Vega Therapeutics
Jun 8, 2026